Cementogenesis and the induction of periodontal tissue regeneration by the osteogenic proteins of the transforming growth factor-beta superfamily.
The antiquity and severity of periodontal diseases are demonstrated by the hard evidence of alveolar bone loss in gnathic remains of the Pliocene/Pleistocene deposits of the Bloubank Valley at Sterkfontein, Swartkrans and Kromdrai in South Africa. Extant Homo has characterized and cloned a superfamily of proteins which include the bone morphogenetic proteins that regulate tooth morphogenesis at different stages of development as temporally and spatially connected events. The induction of cementogenesis, periodontal ligament and alveolar bone regeneration are regulated by the co-ordinated expression of bone morphogenetic proteins. Naturally derived and recombinant human bone morphogenetic proteins induce periodontal tissue regeneration in mammals. Morphological analyses on undecalcified sections cut at 3-6 mum on a series of mandibular molar Class II and III furcation defects induced in the non-human primate Papio ursinus show the induction of cementogenesis. Sharpey's fibers nucleate as a series of composite collagen bundles within the cementoid matrix in close relation to embedded cementocytes. Osteogenic protein-1 and bone morphogenetic protein-2 possess a structure-activity profile, as shown by the morphology of tissue regeneration, preferentially cementogenic and osteogenic, respectively. In Papio ursinus, transforming growth factor-beta(3) also induces cementogenesis, with Sharpey's fibers inserting into newly formed alveolar bone. Capillary sprouting and invasion determine the sequential insertion and alignment of individual collagenic bundles. The addition of responding stem cells prepared by finely mincing fragments of autogenous rectus abdominis muscle significantly enhances the induction of periodontal tissue regeneration when combined with transforming growth factor-beta(3) implanted in Class II and III furcation defects of Papio ursinus.
Bone Research Unit, Medical Research Council/University of the Witwatersrand, 7 York Road Medical School, 2193 Parktown, Johannesburg, South Africa. ugo.ripamonti@wits.ac.za
U
U
Ripamonti
J-C
JC
Petit
J
J
Teare
D016301:Alveolar Bone Loss / Q000266:history / Q000503:physiopathology*; D000818:Animals; D019485:Bone Morphogenetic Proteins / Q000502:physiology*; D025021:Cementogenesis / Q000502:physiology*; D018507:Gene Expression Regulation, Developmental; D049690:History, Ancient; D015186:Hominidae; D006801:Humans; D018919:Neovascularization, Physiologic / Q000502:physiology; D010012:Osteogenesis / Q000502:physiology*; D048549:Papio ursinus; D010513:Periodontal Ligament / Q000502:physiology; D011994:Recombinant Proteins / Q000494:pharmacology; D017568:Rectus Abdominis / Q000187:drug effects; D012038:Regeneration / Q000502:physiology*; D013019:South Africa; D053782:Transforming Growth Factor beta3 / Q000494:pharmacology / Q000502:physiology
D019485:Bone Morphogenetic Proteins; D011994:Recombinant Proteins; D053782:Transforming Growth Factor beta3